BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cingöz A, Ozyerli-Goknar E, Morova T, et al. (2024) Editorial Expression of Concern: Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene |
Cingöz A, Ozyerli-Goknar E, Morova T, et al. (2021) Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization. Oncogene. 40: 3201-3216 |
Senbabaoglu F, Aksu AC, Cingoz A, et al. (2020) Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma. Frontiers in Neuroscience. 14: 578316 |
Sur-Erdem I, Muslu K, Pınarbası N, et al. (2020) TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway. Neurological Research. 1-9 |
Saraç H, Morova T, Pires E, et al. (2019) Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer. Oncogene |
Ozyerli-Goknar E, Sur-Erdem I, Seker F, et al. (2019) The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma Cell Death and Disease. 10: 894 |
Seker F, Cingoz A, Sur-Erdem İ, et al. (2019) Identification of as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling. Cancers. 11 |
Kaya-Aksoy E, Cingoz A, Senbabaoglu F, et al. (2019) The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme. Cell Death Discovery. 5: 64 |
Kurt IC, Sur I, Kaya E, et al. (2017) KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL. Cell Death & Disease. 8: e2897 |
Idot, Sur l, Muslu K, et al. (2017) Abstract 4164: TRAIL resistance of glioblastoma cells is associated with DNA damage signalling network Cancer Research. 77: 4164-4164 |